HIV antigen variability in arc/aids

Research output: Contribution to journalArticle

Abstract

To define the natural variability of human immunodeficiency virus p24 antigen (HIV Ag) over time in untreated HIV-infected patients, we analyzed the percentage change of serum HIV Ag in 40 antigenemic ARC/AIDS subjects receiving placebo in a 24 week clinical trial. When grouped by month of observation, no differences in HIV Ag change were seen among all five 1 month observation periods ip > 0.4). After all 105 monthly changes (median of 3 per subject) were pooled, the mean monthly HIV Ag change was 0% change (standard deviation: 77% increase, 44% decrease). Furthermore, HIV Ag changes did not differ among all lengths of observation (from 1 to 5 months using all possible pairwise combinations of HIV Ag levels, p > 0.4). CD4 T-cell changes over the whole study did not correlate with HIV Ag changes over the same period. Knowledge of this broad HIV Ag variability should be useful in calculating sample size and in choosing categorical responses unlikely to occur spontaneously in clinical trials of antiviral agents where HIV Ag changes are used as surrogate markers of efficacy.

Original languageEnglish (US)
Pages (from-to)847-850
Number of pages4
JournalJournal of acquired immune deficiency syndromes
Volume4
Issue number9
DOIs
StatePublished - Sep 1991

Keywords

  • Antiviral therapy
  • HIV antigen
  • Sample size
  • p24 antigen

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'HIV antigen variability in arc/aids'. Together they form a unique fingerprint.

  • Cite this